Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cassava Sciences, Inc. - Common Stock (NQ: SAVA )

2.340 -0.070 (-2.90%)
Streaming Delayed Price Updated: 1:00 PM EST, Dec 24, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cassava Sciences, Inc. - Common Stock

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
34 35 Next >
Why Cassava Sciences Stock Soared Today
Investors cheered the arrival of a trio of new board members. 
Via The Motley Fool
Cassava Sciences Appoints Three New Members to its Board of Directors
Dr. Nicaise, Mr. Gravier and Mr. Anderson have years of experience in drug development, healthcare M&A and working with the U.S. Government 
From Cassava Sciences, Inc.
Via GlobeNewswire
7 High-Risk, High-Reward Stocks for the Extreme Contrarian
While most folks should stick on the established road, these stock picks for contrarian investors might tempt the intrepid. 
Via InvestorPlace
Cassava Sciences Reports Third Quarter 2023 Financial and Operating Results
From Cassava Sciences, Inc.
Via GlobeNewswire
1 Big Red Flag to Fear When a Stock Is Down
Playing the blame game does not make for an effective turnaround strategy. 
Via The Motley Fool
Why Cassava Sciences Stock Surged Today
Cassava Sciences, Inc. (NASDAQ: SAVA) shares are trading higher after the company announced MRI data suggested simufilam is not associated with amyloid- 
Via Benzinga
Cassava Sciences Inc. (NASDAQ: SAVA) Leading the Way in Tuesday Trading Based on Percentage Gain
Via Investor Brand Network
Cassava Sciences Completes Enrollment for Pivotal Phase 3 Program of Simufilam in Alzheimer’s Disease
From Cassava Sciences, Inc.
Via GlobeNewswire
MRI Data Suggest Simufilam is Not Associated with Amyloid-related Imaging Abnormalities (ARIA)
From Cassava Sciences, Inc.
Via GlobeNewswire
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
7 Stocks That Are Heading for a Train Wreck
There's always a bear market somewhere. Here are seven stocks to sell that investors should definitely unload now. 
Via InvestorPlace
Why Nokia Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers 
Via Benzinga
Wyndham Hotels & Resorts, Olink Holding And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded lower, with the Dow Jones falling around 50 points on Tuesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
Exposures US Equities
Why Is SciSparc (SPRC) Stock Up 105% Today?
SciSparc stock is rising higher on Tuesday as shares of SPRC regain compliance with the Nasdaq minimum bid listing requirement. 
Via InvestorPlace
SAVA Stock Continues to Plunge on Misconduct Allegations
An investigation into one of Cassava Sciences' advisors is pushing shares down. Here's why investors should worry about SAVA stock. 
Via InvestorPlace
Why Belden Shares Are Trading Lower By Over 25%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Sigma Additive Solutions, Inc. (NASDAQ: SASI) shares jumped 196% to $7.34 after the company announced the signing of a definitive agreement for the acquisition of NextTrip Holdings, Inc. 
Via Benzinga
Why Cassava Sciences Stock Is Tanking Today
Investors are worried about a leaked report related to alleged data manipulation for Cassava's Alzheimer's disease treatment candidate. 
Via The Motley Fool
SAVA Stock Alert: Cassava Sciences Addresses Leaked Report
SAVA stock is falling hard following the publication of a City University of New York report by Science regarding Hoau-Yan Wang. 
Via InvestorPlace
UK Authority Approves Microsoft's $69B Activision Blizzard Acquisition, Google Search Gets Generative AI Boost, Big Banks Earnings: Today's Top Stories
Benzinga 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Alzheimer's-Focused Cassava Sciences Faces Controversy as Key Collaborator Accused of Scientific Misconduct
Cassava Sciences Inc (NASDAQ: SAVA), the Alzheimer-focused firm, is facing further controversy as a recent investigation by the City University of New York (CUNY) has implicated neuroscientist Hoau-Yan... 
Via Benzinga
Why Comtech Telecommunications Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
Gainers Oblong, Inc. (NASDAQ: OBLG) shares rose 295.7% to $1.16 in pre-market trading. 
Via Benzinga
Outset Medical, SMART Global And Other Big Stocks Moving Lower In Friday's Pre-Market Session
U.S. stock futures traded lower this morning on Friday. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
Statement by Cassava Sciences Regarding an Internal CUNY Report Leaked to the Press
From Cassava Sciences, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Why Shares of Cassava Sciences Soared This Week
Cassava bounced back from hitting a 52-week low to start the week. 
Via The Motley Fool
Cassava Sciences to Present at the Jefferies Biotech CNS/Neuro Summit in NY
CEO to Present on Wednesday, October 11th, at 10:30am ET 
From Cassava Sciences, Inc.
Via GlobeNewswire
Cassava Sciences Completes Patient Enrollment for Pivotal Phase 3 Clinical Trial of Oral Simufilam in Alzheimer’s Disease
From Cassava Sciences, Inc.
Via GlobeNewswire
Stocks That Hit 52-Week Lows On Monday
  On Monday, 369 companies set new 52-week lows. 
Via Benzinga
Cassava Sciences Announces Positive Interim Safety Review of Simufilam On-going Phase 3 Trials in Patients with Alzheimer’s Disease
From Cassava Sciences, Inc.
Via GlobeNewswire
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
34 35 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.